MMAE | MMAE BRENTUXIMAB VEDOTIN POLATUZUMAB VEDOTIN-PIIQ ENFORTUMAB VEDOTIN-EJFV | ATC L01FX05
ANTINEOPLASTIC TREATMENT OF PATIENTS WITH HODGKIN LYMPHOMA, SYSTEMIC ANAPLASTIC LARGE CELL LYMPHOMA (SALCL), PRIMARY CUTANEOUS ANAPLASTIC LARGE CELL LYMPHOMA (PCALCL) OR CD30EXPRESSING MYCOSIS FUNGOIDES (MF) CD30-DIRECTED ANTIBODY-DRUG CONJUGATE (ADC) LEAD TO THE RELEASE OF THE MICROTUBULE DISRUPTING AGENT MMAE | INJECTION INTRAVENOUS | PPB 75 PERCENT | TUBULIN PDB 5IYZ (TUBULIN-MMAE COMPLEX) LIGAND CODE = 4Q5 (link to the list of PDB complexes) Download experimental 3D coordinates of 4Q5 with added hydrogens | TUBULIN TBB1_HUMAN INHIBITOR UNIPROT P04350 more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |